Anavex Life Sciences Corp (AVXL)

[Jonjones325]

So the current SOC for Alz is not understood. They don’t know how or why it works or if it even is targeting the right thing. Or if the thing they are targeting should even be the target.

They have not explored the MOA. Guess there’s no reason to. To see the how’s and why’s. And why would they since they are making billions without having to. And if they attempted to, it might actually backfire on them.

Now comes 2-73 with an extraordinary amount of detail and safety. Hard to dismiss if it proves to be better.

This is why and how it works. This is why it’s better and this is how we lead the way to understanding CNS diseases. And we’ve shown our platforms effectiveness across diseases and populations.

It’s be amazingly messed up for the FDA to dismiss it and make us to another trial. But I guess we shouldn’t underestimate the power of big pharmas influence.